StonvexLoading…
StonvexStonvexStonvexCore line items from LE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-30 | Annual 2025 2025-01-31 | Annual 2024 2024-02-02 | Annual 2023 2023-01-27 |
|---|---|---|---|---|
Revenue | $1.34B | $1.36B | $1.47B | $1.56B |
Operating Income | $44.27M | $50.96M | $-77.52M | $24.73M |
Net Income | $5.51M | $6.23M | $-130.68M | $-12.53M |
EPS (Diluted) | $0.18 | $0.20 | $-4.09 | $-0.38 |
Total Assets | $751.07M | $765.48M | $811.48M | $1.08B |
Total Liabilities | $506.77M | $526.26M | $569.89M | $701.40M |
Cash & Equivalents | $17.69M | $16.18M | $25.31M | $39.56M |
Free Cash Flow OCF − CapEx | $20.40M | $15.37M | $95.65M | $-68.17M |
Shares Outstanding | 30.57M | 30.84M | 31.43M | 32.63M |